Diagonal Therapeutics

Advancing clustering antibodies to correct disease at the root

Watertown, United States · Founded 2022

Employees
11–50
Founded
2022
Last Round
Series BJan 2026
Rounds
2

About

Diagonal Therapeutics pioneers a new class of clustering antibody medicines designed to correct the root causes of severe genetic and immune-mediated diseases. Founded in 2022, the company's lead program DIAG723 targets HHT by restoring ALK1 signaling and is advancing toward clinical trials in 2026.

Summary

Diagonal Therapeutics is a Biotech company based in Watertown, United States, founded in 2022. Its most recent funding was a Series B round in Jan 2026. Investors include BVF Partners, Atlas Venture and Sanofi Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2026

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Diagonal Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/diagonal-therapeutics"><img src="https://indexed.vc/api/badge/company/diagonal-therapeutics" alt="Diagonal Therapeutics on Indexed.vc" width="260" height="76" /></a>